ARCHIVES

CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

Reports On Nutrition & Cancer Show Needs For More Clinical Studies

September 5, 1975

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

The Education Of Dan Flood Gets $60 Million Increase For NCI; House Votes HEW Money Bill

July 5, 1974

House Bill Seeks Coverage for Care Planning, Reviving Proposal Once Maligned By The Right

September 6, 2013